← Leaderboards
Carmen Priolo
Brigham And Women'S Hospital
$3,651,366
Attributed
$4,680,113
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $884K · FY2016–23$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,680,113 · 3
By mechanism
R01$4,245,245 · 2
R56$434,868 · 1
Top collaborators
- Elizabeth P Henske6 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Elizabeth P Henske$25,563,270
- David J. Kwiatkowski$31,996,627
- Victor W Hsu$19,152,350
- Barbara Balestrieri$2,989,471
- Bruce D Levy$29,805,980
Others in their field
Top investigators on “Metabolic”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,260,706
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$124,168,384
- Carol Nesel · Westat$116,355,411
Research focus
MetabolicCellsIn VivoPathogenesisPathway InteractionsMutationTherapeutic TargetMolecularRecurrenceTargeted TreatmentCell ProliferationIn VitroGeneticImaging BiomarkerCitric Acid CycleImpairmentGlutathioneCell GrowthClear CellHomeostasisFrap1 GeneEnzymesGamma-Glutamyl TransferaseCellular Metabolic Process
Grant awards (12)
Lipid homeostasis and mitochondrial fitness in LAM pathogenesis and therapy$434,868
R56 · FY2023 · HL · contact PI
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma$399,620
R01 · FY2022 · CA
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma$407,775
R01 · FY2021 · CA
Targeting Choline Phospholipid Metabolism in Lymphangioleiomyomatosis$436,001
R01 · FY2020 · HL · contact PI
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma$375,563
R01 · FY2020 · CA
Targeting Choline Phospholipid Metabolism in Lymphangioleiomyomatosis$436,000
R01 · FY2019 · HL · contact PI
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma$411,468
R01 · FY2019 · CA
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma$36,579
R01 · FY2019 · CA
Targeting Choline Phospholipid Metabolism in Lymphangioleiomyomatosis$436,000
R01 · FY2018 · HL · contact PI
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma$426,489
R01 · FY2018 · CA
Targeting Choline Phospholipid Metabolism in Lymphangioleiomyomatosis$436,000
R01 · FY2017 · HL · contact PI
Targeting Choline Phospholipid Metabolism in Lymphangioleiomyomatosis$443,750
R01 · FY2016 · HL · contact PI